TY - JOUR AU - Beatty, G. L. AU - Haas, A. R. AU - Maus, M. V. AU - Torigian, D. A. AU - Soulen, M. C. AU - Plesa, G. PY - 2014 DA - 2014// TI - Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0170 DO - 10.1158/2326-6066.CIR-13-0170 ID - Beatty2014 ER - TY - JOUR AU - Grupp, S. A. AU - Kalos, M. AU - Barrett, D. AU - Aplenc, R. AU - Porter, D. L. AU - Rheingold, S. R. PY - 2013 DA - 2013// TI - Chimeric antigen receptor-modified T cells for acute lymphoid leukemia JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1215134 DO - 10.1056/NEJMoa1215134 ID - Grupp2013 ER - TY - JOUR AU - Johnson, L. A. AU - Scholler, J. AU - Ohkuri, T. AU - Kosaka, A. AU - Patel, P. R. AU - McGettigan, S. E. PY - 2015 DA - 2015// TI - Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa4963 DO - 10.1126/scitranslmed.aaa4963 ID - Johnson2015 ER - TY - JOUR AU - Barrett, D. M. AU - Grupp, S. A. AU - June, C. H. PY - 2015 DA - 2015// TI - Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street JO - J Immunol VL - 195 UR - https://doi.org/10.4049/jimmunol.1500751 DO - 10.4049/jimmunol.1500751 ID - Barrett2015 ER - TY - JOUR AU - Maus, M. V. AU - June, C. H. PY - 2016 DA - 2016// TI - Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1433 DO - 10.1158/1078-0432.CCR-15-1433 ID - Maus2016 ER - TY - JOUR AU - Curran, K. J. AU - Pegram, H. J. AU - Brentjens, R. J. PY - 2012 DA - 2012// TI - Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions JO - J Gene Med VL - 14 UR - https://doi.org/10.1002/jgm.2604 DO - 10.1002/jgm.2604 ID - Curran2012 ER - TY - JOUR AU - Lamers, C. H. AU - Sleijfer, S. AU - Vulto, A. G. AU - Kruit, W. H. AU - Kliffen, M. AU - Debets, R. PY - 2006 DA - 2006// TI - Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.05.9964 DO - 10.1200/JCO.2006.05.9964 ID - Lamers2006 ER - TY - JOUR AU - Lamers, C. H. AU - Sleijfer, S. AU - Steenbergen, S. AU - Elzakker, P. AU - Krimpen, B. AU - Groot, C. PY - 2013 DA - 2013// TI - Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.17 DO - 10.1038/mt.2013.17 ID - Lamers2013 ER - TY - JOUR AU - Morgan, R. A. AU - Yang, J. C. AU - Kitano, M. AU - Dudley, M. E. AU - Laurencot, C. M. AU - Rosenberg, S. A. PY - 2010 DA - 2010// TI - Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2010.24 DO - 10.1038/mt.2010.24 ID - Morgan2010 ER - TY - JOUR AU - Parkhurst, M. R. AU - Yang, J. C. AU - Langan, R. C. AU - Dudley, M. E. AU - Nathan, D. A. AU - Feldman, S. A. PY - 2011 DA - 2011// TI - T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2010.272 DO - 10.1038/mt.2010.272 ID - Parkhurst2011 ER - TY - JOUR AU - Cameron, B. J. AU - Gerry, A. B. AU - Dukes, J. AU - Harper, J. V. AU - Kannan, V. AU - Bianchi, F. C. PY - 2013 DA - 2013// TI - Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006034 DO - 10.1126/scitranslmed.3006034 ID - Cameron2013 ER - TY - JOUR AU - Linette, G. P. AU - Stadtmauer, E. A. AU - Maus, M. V. AU - Rapoport, A. P. AU - Levine, B. L. AU - Emery, L. PY - 2013 DA - 2013// TI - Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-03-490565 DO - 10.1182/blood-2013-03-490565 ID - Linette2013 ER - TY - JOUR AU - Debets, R. AU - Willemsen, R. AU - Bolhuis, R. PY - 2002 DA - 2002// TI - Adoptive transfer of T-cell immunity: gene transfer with MHC-restricted receptors JO - Trends Immunol VL - 23 UR - https://doi.org/10.1016/S1471-4906(02)02290-1 DO - 10.1016/S1471-4906(02)02290-1 ID - Debets2002 ER - TY - JOUR AU - Zhang, T. AU - He, X. AU - Tsang, T. C. AU - Harris, D. T. PY - 2004 DA - 2004// TI - Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function JO - Cancer Gene Ther VL - 11 UR - https://doi.org/10.1038/sj.cgt.7700703 DO - 10.1038/sj.cgt.7700703 ID - Zhang2004 ER - TY - JOUR AU - DeFrancesco, L. PY - 2014 DA - 2014// TI - CAR-T cell therapy seeks strategies to harness cytokine storm JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt0714-604 DO - 10.1038/nbt0714-604 ID - DeFrancesco2014 ER - TY - JOUR AU - Berg, J. H. AU - Gomez-Eerland, R. AU - Wiel, B. AU - Hulshoff, L. AU - Broek, D. AU - Bins, A. PY - 2015 DA - 2015// TI - Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2015.60 DO - 10.1038/mt.2015.60 ID - Berg2015 ER - TY - JOUR AU - Zhao, Y. AU - Moon, E. AU - Carpenito, C. AU - Paulos, C. M. AU - Liu, X. AU - Brennan, A. L. PY - 2010 DA - 2010// TI - Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-2880 DO - 10.1158/0008-5472.CAN-10-2880 ID - Zhao2010 ER - TY - STD TI - Riet T, Holzinger A, Dörrie J, Schaft N, Schuler G, Abken H. Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy. Methods Mol Biol. 2013;969:187–201. ID - ref18 ER - TY - JOUR AU - Schaft, N. AU - Dorrie, J. AU - Muller, I. AU - Beck, V. AU - Baumann, S. AU - Schunder, T. PY - 2006 DA - 2006// TI - A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes JO - Cancer Immunol Immunother VL - 55 UR - https://doi.org/10.1007/s00262-005-0098-2 DO - 10.1007/s00262-005-0098-2 ID - Schaft2006 ER - TY - JOUR AU - Cheadle, E. J. AU - Sheard, V. AU - Hombach, A. A. AU - Chmielewski, M. AU - Riet, T. AU - Berrevoets, C. PY - 2012 DA - 2012// TI - Chimeric antigen receptors for T-cell based therapy JO - Methods Mol Biol VL - 907 UR - https://doi.org/10.1007/978-1-61779-974-7_36 DO - 10.1007/978-1-61779-974-7_36 ID - Cheadle2012 ER - TY - JOUR AU - Birkholz, K. AU - Hofmann, C. AU - Hoyer, S. AU - Schulz, B. AU - Harrer, T. AU - Kampgen, E. PY - 2009 DA - 2009// TI - A fast and robust method to clone and functionally validate T-cell receptors JO - J Immunol Methods VL - 346 UR - https://doi.org/10.1016/j.jim.2009.05.001 DO - 10.1016/j.jim.2009.05.001 ID - Birkholz2009 ER - TY - JOUR AU - Zhao, Y. AU - Zheng, Z. AU - Robbins, P. F. AU - Khong, H. T. AU - Rosenberg, S. A. AU - Morgan, R. A. PY - 2005 DA - 2005// TI - Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.7.4415 DO - 10.4049/jimmunol.174.7.4415 ID - Zhao2005 ER - TY - JOUR AU - Zhao, Y. AU - Zheng, Z. AU - Cohen, C. J. AU - Gattinoni, L. AU - Palmer, D. C. AU - Restifo, N. P. PY - 2006 DA - 2006// TI - High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation JO - Mol Ther VL - 13 UR - https://doi.org/10.1016/j.ymthe.2005.07.688 DO - 10.1016/j.ymthe.2005.07.688 ID - Zhao2006 ER - TY - JOUR AU - Koning, F. AU - Maloy, W. L. AU - Cohen, D. AU - Coligan, J. E. PY - 1987 DA - 1987// TI - Independent association of T cell receptor beta and gamma chains with CD3 in the same cell JO - J Exp Med VL - 166 UR - https://doi.org/10.1084/jem.166.2.595 DO - 10.1084/jem.166.2.595 ID - Koning1987 ER - TY - JOUR AU - Saito, T. AU - Hochstenbach, F. AU - Marusic-Galesic, S. AU - Kruisbeek, A. M. AU - Brenner, M. AU - Germain, R. N. PY - 1988 DA - 1988// TI - Surface expression of only gamma delta and/or alpha beta T cell receptor heterodimers by cells with four (alpha, beta, gamma, delta) functional receptor chains JO - J Exp Med VL - 168 UR - https://doi.org/10.1084/jem.168.3.1003 DO - 10.1084/jem.168.3.1003 ID - Saito1988 ER - TY - JOUR AU - Veken, L. T. AU - Coccoris, M. AU - Swart, E. AU - Falkenburg, J. H. AU - Schumacher, T. N. AU - Heemskerk, M. H. PY - 2009 DA - 2009// TI - Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.182.1.164 DO - 10.4049/jimmunol.182.1.164 ID - Veken2009 ER - TY - JOUR AU - Morita, C. T. AU - Beckman, E. M. AU - Bukowski, J. F. AU - Tanaka, Y. AU - Band, H. AU - Bloom, B. R. PY - 1995 DA - 1995// TI - Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells JO - Immunity VL - 3 UR - https://doi.org/10.1016/1074-7613(95)90178-7 DO - 10.1016/1074-7613(95)90178-7 ID - Morita1995 ER - TY - JOUR AU - Tanaka, Y. AU - Morita, C. T. AU - Tanaka, Y. AU - Nieves, E. AU - Brenner, M. B. AU - Bloom, B. R. PY - 1995 DA - 1995// TI - Natural and synthetic non-peptide antigens recognized by human gamma delta T cells JO - Nature VL - 375 UR - https://doi.org/10.1038/375155a0 DO - 10.1038/375155a0 ID - Tanaka1995 ER - TY - JOUR AU - Chiplunkar, S. AU - Dhar, S. AU - Wesch, D. AU - Kabelitz, D. PY - 2009 DA - 2009// TI - gammadelta T cells in cancer immunotherapy: current status and future prospects JO - Immunotherapy VL - 1 ID - Chiplunkar2009 ER - TY - JOUR AU - Gober, H. J. AU - Kistowska, M. AU - Angman, L. AU - Jeno, P. AU - Mori, L. AU - De, L. G. PY - 2003 DA - 2003// TI - Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells JO - J Exp Med VL - 197 UR - https://doi.org/10.1084/jem.20021500 DO - 10.1084/jem.20021500 ID - Gober2003 ER - TY - JOUR AU - Nedellec, S. AU - Sabourin, C. AU - Bonneville, M. AU - Scotet, E. PY - 2010 DA - 2010// TI - NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.1000373 DO - 10.4049/jimmunol.1000373 ID - Nedellec2010 ER - TY - JOUR AU - Lehner, M. AU - Gotz, G. AU - Proff, J. AU - Schaft, N. AU - Dorrie, J. AU - Full, F. PY - 2012 DA - 2012// TI - Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031210 DO - 10.1371/journal.pone.0031210 ID - Lehner2012 ER - TY - JOUR AU - Kobayashi, H. AU - Tanaka, Y. AU - Yagi, J. AU - Osaka, Y. AU - Nakazawa, H. AU - Uchiyama, T. PY - 2007 DA - 2007// TI - Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study JO - Cancer Immunol Immunother VL - 56 UR - https://doi.org/10.1007/s00262-006-0199-6 DO - 10.1007/s00262-006-0199-6 ID - Kobayashi2007 ER - TY - JOUR AU - Kobayashi, H. AU - Tanaka, Y. AU - Shimmura, H. AU - Minato, N. AU - Tanabe, K. PY - 2010 DA - 2010// TI - Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma JO - Anticancer Res VL - 30 ID - Kobayashi2010 ER - TY - JOUR AU - Nakajima, J. AU - Murakawa, T. AU - Fukami, T. AU - Goto, S. AU - Kaneko, T. AU - Yoshida, Y. PY - 2010 DA - 2010// TI - A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells JO - Eur J Cardiothorac Surg VL - 37 UR - https://doi.org/10.1016/j.ejcts.2009.11.051 DO - 10.1016/j.ejcts.2009.11.051 ID - Nakajima2010 ER - TY - JOUR AU - Coleman, R. E. AU - Winter, M. C. AU - Cameron, D. AU - Bell, R. AU - Dodwell, D. AU - Keane, M. M. PY - 2010 DA - 2010// TI - The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605604 DO - 10.1038/sj.bjc.6605604 ID - Coleman2010 ER - TY - JOUR AU - Nussbaumer, O. AU - Gruenbacher, G. AU - Gander, H. AU - Komuczki, J. AU - Rahm, A. AU - Thurnher, M. PY - 2013 DA - 2013// TI - Essential requirements of zoledronate-induced cytokine and gammadelta T cell proliferative responses JO - J Immunol VL - 191 UR - https://doi.org/10.4049/jimmunol.1300603 DO - 10.4049/jimmunol.1300603 ID - Nussbaumer2013 ER - TY - JOUR AU - Deniger, D. C. AU - Switzer, K. AU - Mi, T. AU - Maiti, S. AU - Hurton, L. AU - Singh, H. PY - 2013 DA - 2013// TI - Bispecific T-cells expressing polyclonal repertoire of endogenous gammadelta T-cell receptors and introduced CD19-specific chimeric antigen receptor JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2012.267 DO - 10.1038/mt.2012.267 ID - Deniger2013 ER - TY - JOUR AU - Veken, L. T. AU - Hagedoorn, R. S. AU - Loenen, M. M. AU - Willemze, R. AU - Falkenburg, J. H. AU - Heemskerk, M. H. PY - 2006 DA - 2006// TI - Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4190 DO - 10.1158/0008-5472.CAN-05-4190 ID - Veken2006 ER - TY - JOUR AU - Dorrie, J. AU - Krug, C. AU - Hofmann, C. AU - Muller, I. AU - Wellner, V. AU - Knippertz, I. PY - 2014 DA - 2014// TI - Human Adenovirus-Specific gamma/delta and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0109944 DO - 10.1371/journal.pone.0109944 ID - Dorrie2014 ER - TY - JOUR AU - Shimizu, K. AU - Shinga, J. AU - Yamasaki, S. AU - Kawamura, M. AU - Dorrie, J. AU - Schaft, N. PY - 2015 DA - 2015// TI - Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and gammadeltaT Cells JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0131477 DO - 10.1371/journal.pone.0131477 ID - Shimizu2015 ER - TY - JOUR AU - Oevermann, L. AU - Lang, P. AU - Feuchtinger, T. AU - Schumm, M. AU - Teltschik, H. M. AU - Schlegel, P. PY - 2012 DA - 2012// TI - Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation JO - Ann N Y Acad Sci VL - 1266 UR - https://doi.org/10.1111/j.1749-6632.2012.06606.x DO - 10.1111/j.1749-6632.2012.06606.x ID - Oevermann2012 ER - TY - JOUR AU - Baitsch, L. AU - Baumgaertner, P. AU - Devevre, E. AU - Raghav, S. K. AU - Legat, A. AU - Barba, L. PY - 2011 DA - 2011// TI - Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI46102 DO - 10.1172/JCI46102 ID - Baitsch2011 ER - TY - JOUR AU - Ohrmalm, L. AU - Smedman, C. AU - Wong, M. AU - Broliden, K. AU - Tolfvenstam, T. AU - Norbeck, O. PY - 2013 DA - 2013// TI - Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia JO - J Intern Med VL - 274 UR - https://doi.org/10.1111/joim.12100 DO - 10.1111/joim.12100 ID - Ohrmalm2013 ER - TY - JOUR AU - Bender, C. AU - Hassel, J. C. AU - Enk, A. PY - 2016 DA - 2016// TI - Immunotherapy of Melanoma JO - Oncol Res Treat VL - 39 UR - https://doi.org/10.1159/000446716 DO - 10.1159/000446716 ID - Bender2016 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Robbins, P. F. AU - Yang, J. C. AU - Hwu, P. AU - Schwartzentruber, D. J. PY - 2002 DA - 2002// TI - Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes JO - Science VL - 298 UR - https://doi.org/10.1126/science.1076514 DO - 10.1126/science.1076514 ID - Dudley2002 ER - TY - JOUR AU - Wick, M. R. AU - Swanson, P. E. AU - Rocamora, A. PY - 1988 DA - 1988// TI - Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors JO - J Cutan Pathol VL - 15 UR - https://doi.org/10.1111/j.1600-0560.1988.tb00544.x DO - 10.1111/j.1600-0560.1988.tb00544.x ID - Wick1988 ER - TY - JOUR AU - Campoli, M. R. AU - Chang, C. C. AU - Kageshita, T. AU - Wang, X. AU - McCarthy, J. B. AU - Ferrone, S. PY - 2004 DA - 2004// TI - Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance JO - Crit Rev Immunol VL - 24 UR - https://doi.org/10.1615/CritRevImmunol.v24.i4.40 DO - 10.1615/CritRevImmunol.v24.i4.40 ID - Campoli2004 ER - TY - STD TI - Krug C, Birkholz K, Paulus A, Schwenkert M, Schmidt P, Hoffmann N, et al. Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone. Cancer Immunol Immunother. 2015;64:1623–35. ID - ref49 ER - TY - JOUR AU - Yadavilli, S. AU - Hwang, E. I. AU - Packer, R. J. AU - Nazarian, J. PY - 2016 DA - 2016// TI - The Role of NG2 Proteoglycan in Glioma JO - Transl Oncol VL - 9 UR - https://doi.org/10.1016/j.tranon.2015.12.005 DO - 10.1016/j.tranon.2015.12.005 ID - Yadavilli2016 ER - TY - JOUR AU - Godal, A. AU - Bruland, O. AU - Haug, E. AU - Aas, M. AU - Fodstad, O. PY - 1986 DA - 1986// TI - Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells JO - Br J Cancer VL - 53 UR - https://doi.org/10.1038/bjc.1986.142 DO - 10.1038/bjc.1986.142 ID - Godal1986 ER - TY - JOUR AU - Wang, X. AU - Osada, T. AU - Wang, Y. AU - Yu, L. AU - Sakakura, K. AU - Katayama, A. PY - 2010 DA - 2010// TI - CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq343 DO - 10.1093/jnci/djq343 ID - Wang2010 ER - TY - JOUR AU - Ozerdem, U. PY - 2006 DA - 2006// TI - Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse JO - Ophthalmic Res VL - 38 UR - https://doi.org/10.1159/000094833 DO - 10.1159/000094833 ID - Ozerdem2006 ER - TY - JOUR AU - Ozerdem, U. PY - 2006 DA - 2006// TI - Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer JO - Prostate VL - 66 UR - https://doi.org/10.1002/pros.20346 DO - 10.1002/pros.20346 ID - Ozerdem2006 ER - TY - JOUR AU - Tordsson, J. M. AU - Ohlsson, L. G. AU - Abrahmsen, L. B. AU - Karlstrom, P. J. AU - Lando, P. A. AU - Brodin, T. N. PY - 2000 DA - 2000// TI - Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma JO - Cancer Immunol Immunother VL - 48 UR - https://doi.org/10.1007/s002620050018 DO - 10.1007/s002620050018 ID - Tordsson2000 ER - TY - STD TI - ADF. 2017 44th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung Göttingen, Germany, March 9–11, 2017. Exper Dermatol. 2017; 26(3): P157. ID - ref56 ER - TY - JOUR PY - 2016 DA - 2016// TI - 2016 Annual Meeting Abstract Supplement JO - J Investig Dermatol VL - 136 ID - ref57 ER - TY - JOUR AU - Hofflin, S. AU - Prommersberger, S. AU - Uslu, U. AU - Schuler, G. AU - Schmidt, C. W. AU - Lennerz, V. PY - 2015 DA - 2015// TI - Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy JO - Cancer Biol Ther VL - 16 UR - https://doi.org/10.1080/15384047.2015.1070981 DO - 10.1080/15384047.2015.1070981 ID - Hofflin2015 ER - TY - STD TI - Kondo M, Izumi T, Fujieda N, Kondo A, Morishita T, Matsushita H, et al. Expansion of human peripheral blood gammadelta T cells using zoledronate. J Vis Exp. 2011; ID - ref59 ER - TY - JOUR AU - Krug, C. AU - Wiesinger, M. AU - Abken, H. AU - Schuler-Thurner, B. AU - Schuler, G. AU - Dorrie, J. PY - 2014 DA - 2014// TI - A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1572-5 DO - 10.1007/s00262-014-1572-5 ID - Krug2014 ER - TY - JOUR AU - Gerer, K. F. AU - Hoyer, S. AU - Dorrie, J. AU - Schaft, N. PY - 2017 DA - 2017// TI - Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins JO - Methods Mol Biol VL - 1499 UR - https://doi.org/10.1007/978-1-4939-6481-9_10 DO - 10.1007/978-1-4939-6481-9_10 ID - Gerer2017 ER - TY - JOUR AU - Birkholz, K. AU - Hombach, A. AU - Krug, C. AU - Reuter, S. AU - Kershaw, M. AU - Kampgen, E. PY - 2009 DA - 2009// TI - Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer JO - Gene Ther VL - 16 UR - https://doi.org/10.1038/gt.2008.189 DO - 10.1038/gt.2008.189 ID - Birkholz2009 ER - TY - STD TI - Uslu U, Schuler G, Dorrie J, Schaft N. Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma. Exp Dermatol. 2016;25:872–9 ID - ref63 ER - TY - JOUR AU - Garrido, C. AU - Paco, L. AU - Romero, I. AU - Berruguilla, E. AU - Stefansky, J. AU - Collado, A. PY - 2012 DA - 2012// TI - MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells JO - Carcinogenesis VL - 33 UR - https://doi.org/10.1093/carcin/bgr318 DO - 10.1093/carcin/bgr318 ID - Garrido2012 ER - TY - JOUR AU - Halary, F. AU - Peyrat, M. A. AU - Champagne, E. AU - Lopez-Botet, M. AU - Moretta, A. AU - Moretta, L. PY - 1997 DA - 1997// TI - Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors JO - Eur J Immunol VL - 27 UR - https://doi.org/10.1002/eji.1830271111 DO - 10.1002/eji.1830271111 ID - Halary1997 ER - TY - JOUR AU - Rothenfusser, S. AU - Buchwald, A. AU - Kock, S. AU - Ferrone, S. AU - Fisch, P. PY - 2002 DA - 2002// TI - Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes JO - Cell Immunol VL - 215 UR - https://doi.org/10.1016/S0008-8749(02)00001-1 DO - 10.1016/S0008-8749(02)00001-1 ID - Rothenfusser2002 ER - TY - JOUR AU - Tas, F. PY - 2012 DA - 2012// TI - Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors JO - J Oncol VL - 2012 UR - https://doi.org/10.1155/2012/647684 DO - 10.1155/2012/647684 ID - Tas2012 ER - TY - JOUR AU - Fiorentini, G. AU - Aliberti, C. AU - Del, C. A. AU - Tilli, M. AU - Rossi, S. AU - Ballardini, P. PY - 2009 DA - 2009// TI - Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study JO - In Vivo VL - 23 ID - Fiorentini2009 ER - TY - STD TI - Xing M, Prajapati HJ, Dhanasekaran R, Lawson DH, Kokabi N, Eaton BR, et al. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. Am J Clin Oncol. 2014;40:27–34. ID - ref69 ER - TY - JOUR AU - June, C. H. AU - Maus, M. V. AU - Plesa, G. AU - Johnson, L. A. AU - Zhao, Y. AU - Levine, B. L. PY - 2014 DA - 2014// TI - Engineered T cells for cancer therapy JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1568-1 DO - 10.1007/s00262-014-1568-1 ID - June2014 ER - TY - JOUR AU - Blankenstein, T. PY - 2005 DA - 2005// TI - The role of tumor stroma in the interaction between tumor and immune system JO - Curr Opin Immunol VL - 17 UR - https://doi.org/10.1016/j.coi.2005.01.008 DO - 10.1016/j.coi.2005.01.008 ID - Blankenstein2005 ER - TY - JOUR AU - Spiotto, M. T. AU - Yu, P. AU - Rowley, D. A. AU - Nishimura, M. I. AU - Meredith, S. C. AU - Gajewski, T. F. PY - 2002 DA - 2002// TI - Increasing tumor antigen expression overcomes “ignorance” to solid tumors via crosspresentation by bone marrow-derived stromal cells JO - Immunity VL - 17 UR - https://doi.org/10.1016/S1074-7613(02)00480-6 DO - 10.1016/S1074-7613(02)00480-6 ID - Spiotto2002 ER - TY - JOUR AU - Soriani, A. AU - Fionda, C. AU - Ricci, B. AU - Iannitto, M. L. AU - Cippitelli, M. AU - Santoni, A. PY - 2013 DA - 2013// TI - Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.26663 DO - 10.4161/onci.26663 ID - Soriani2013 ER - TY - JOUR AU - Olson, B. M. AU - McNeel, D. G. PY - 2012 DA - 2012// TI - Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence JO - Exp Rev Vaccines VL - 11 UR - https://doi.org/10.1586/erv.12.107 DO - 10.1586/erv.12.107 ID - Olson2012 ER - TY - JOUR AU - Xiong, Y. AU - Bensoussan, D. AU - Decot, V. PY - 2015 DA - 2015// TI - Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies JO - Transfus Med Rev VL - 29 UR - https://doi.org/10.1016/j.tmrv.2015.07.001 DO - 10.1016/j.tmrv.2015.07.001 ID - Xiong2015 ER - TY - JOUR AU - Sugie, T. AU - Murata-Hirai, K. AU - Iwasaki, M. AU - Morita, C. T. AU - Li, W. AU - Okamura, H. PY - 2013 DA - 2013// TI - Zoledronic acid-induced expansion of gammadelta T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells JO - Cancer Immunol Immunother VL - 62 UR - https://doi.org/10.1007/s00262-012-1368-4 DO - 10.1007/s00262-012-1368-4 ID - Sugie2013 ER - TY - JOUR AU - Deniger, D. C. AU - Maiti, S. N. AU - Mi, T. AU - Switzer, K. C. AU - Ramachandran, V. AU - Hurton, L. V. PY - 2014 DA - 2014// TI - Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-3451 DO - 10.1158/1078-0432.CCR-13-3451 ID - Deniger2014 ER - TY - JOUR AU - Maus, M. V. AU - Fraietta, J. A. AU - Levine, B. L. AU - Kalos, M. AU - Zhao, Y. AU - June, C. H. PY - 2014 DA - 2014// TI - Adoptive immunotherapy for cancer or viruses JO - Annu Rev Immunol VL - 32 UR - https://doi.org/10.1146/annurev-immunol-032713-120136 DO - 10.1146/annurev-immunol-032713-120136 ID - Maus2014 ER - TY - JOUR AU - Robbins, P. F. AU - Dudley, M. E. AU - Wunderlich, J. AU - El-Gamil, M. AU - Li, Y. F. AU - Zhou, J. PY - 2004 DA - 2004// TI - Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.12.7125 DO - 10.4049/jimmunol.173.12.7125 ID - Robbins2004 ER - TY - JOUR AU - Kaiser, A. D. AU - Assenmacher, M. AU - Schroder, B. AU - Meyer, M. AU - Orentas, R. AU - Bethke, U. PY - 2015 DA - 2015// TI - Towards a commercial process for the manufacture of genetically modified T cells for therapy JO - Cancer Gene Ther VL - 22 UR - https://doi.org/10.1038/cgt.2014.78 DO - 10.1038/cgt.2014.78 ID - Kaiser2015 ER - TY - JOUR AU - MacFarlane, A. W. AU - Jillab, M. AU - Plimack, E. R. AU - Hudes, G. R. AU - Uzzo, R. G. AU - Litwin, S. PY - 2014 DA - 2014// TI - PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0133 DO - 10.1158/2326-6066.CIR-13-0133 ID - MacFarlane2014 ER - TY - JOUR AU - Shi, F. AU - Shi, M. AU - Zeng, Z. AU - Qi, R. Z. AU - Liu, Z. W. AU - Zhang, J. Y. PY - 2011 DA - 2011// TI - PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients JO - Int J Cancer VL - 128 UR - https://doi.org/10.1002/ijc.25397 DO - 10.1002/ijc.25397 ID - Shi2011 ER - TY - STD TI - Takano S, Saito H, Ikeguchi M: An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer. Surg Today. 2016;46:1341–7. ID - ref83 ER - TY - JOUR AU - Waki, K. AU - Yamada, T. AU - Yoshiyama, K. AU - Terazaki, Y. AU - Sakamoto, S. AU - Matsueda, S. PY - 2014 DA - 2014// TI - PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer JO - Cancer Sci VL - 105 UR - https://doi.org/10.1111/cas.12502 DO - 10.1111/cas.12502 ID - Waki2014 ER - TY - JOUR AU - Critchley-Thorne, R. J. AU - Yan, N. AU - Nacu, S. AU - Weber, J. AU - Holmes, S. P. AU - Lee, P. P. PY - 2007 DA - 2007// TI - Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma JO - PLoS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040176 DO - 10.1371/journal.pmed.0040176 ID - Critchley-Thorne2007 ER - TY - JOUR AU - Critchley-Thorne, R. J. AU - Simons, D. L. AU - Yan, N. AU - Miyahira, A. K. AU - Dirbas, F. M. AU - Johnson, D. L. PY - 2009 DA - 2009// TI - Impaired interferon signaling is a common immune defect in human cancer JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0901329106 DO - 10.1073/pnas.0901329106 ID - Critchley-Thorne2009 ER -